Eric Woodard, MD, board-certified neurosurgeon and chief medical officer of InVivo Therapeutics, will participate in an FDA trial of InVivo's implantable scaffold device for treatment of spinal cord injuries, according to a wbur report. Dr. Woodard will implant the biodegradable device, which is designed to stabilize spinal cord injuries within six weeks and then dissolve, in the spinal cords of five patients.
InVivo's small scale study is the first human trial of a spinal cord treatment device.
InVivo is a Cambridge, Mass.-based medical device company focused on the treatment of spinal cord injuries.
Dr. Woodard also currently serves as the chief of neurosurgery at New England Baptist Hospital in Boston.
More Articles on Spine:
Dr. Jeffery Carlson Performs Procedure With SpineFrontier's FacetFuse Screw System
Alaska Native Medical Center Names Dr. Roland Torres Clinical Director
7 Things for Spine Surgeons to Know for Thursday
InVivo's small scale study is the first human trial of a spinal cord treatment device.
InVivo is a Cambridge, Mass.-based medical device company focused on the treatment of spinal cord injuries.
Dr. Woodard also currently serves as the chief of neurosurgery at New England Baptist Hospital in Boston.
More Articles on Spine:
Dr. Jeffery Carlson Performs Procedure With SpineFrontier's FacetFuse Screw System
Alaska Native Medical Center Names Dr. Roland Torres Clinical Director
7 Things for Spine Surgeons to Know for Thursday